[Weekly funding roundup] Venture investments continue to remain lacklustre; Indian startups raise $113M yourstory.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yourstory.com Daily Mail and Mail on Sunday newspapers.
Opinions expressed by
You re reading Entrepreneur India, an international franchise of Entrepreneur Media.
Illumina accelerator-backed precision oncology startup 4baseCare announced on Thursday to have raised an investment of $2 million in a pre-Series A funding round led by investors Mount Judi Ventures, growX Ventures, Season Two Ventures, First In Ventures, and a few strategic angel investors.
The company will utilize the funds for expansion of the genomic tests portfolio and for increasing its geographical presence across Asia. Additionally, it will also focus on strengthening its R&D and operations.
“Access to advanced technology, which can help improve treatment and care should be for everyone. Our vision is to leverage on technology to develop affordable solutions to personalize patient care in Oncology,” said Hitesh Goswami, chief executive officer, 4baseCare.
4baseCare raises $2 M for expansion of genomic tests portfolio
4baseCare raises $2 M for expansion of genomic tests portfolio
12 March 2021 | News Led by investors Mount Judi Ventures, growX Ventures, Season Two Ventures, First In Ventures and a few strategic angel investors
L-R- Hitesh Goswami, Kshitij Rishi
4baseCare, an Illumina Accelerator-backed precision oncology startup based in Bengaluru, has raised an investment of $2 M, led by investors Mount Judi Ventures, growX Ventures, Season Two Ventures, First In Ventures and a few strategic angel investors.
4baseCare aims to make precision oncology a standard of care in Asia by increasing the utilisation of genomic tests in oncology and is working towards developing a first of its kind, Indian population-specific gene panel that will analyse a large number of genes for cancer-associated mutations to identify optimal treatment options leading to improved outcomes.